Toripalimab Plus Bevacizumab and Chemotherapy as Neoadjuvant Therapy in Advanced MSI-H or dMMR Colorectal Cancer

NCT04988191 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Carcinoma

Interventions

DRUG: Toripalimab
DRUG: Bevacizumab
DRUG: Irinotecan

Sponsor

Peking University